Facilitating phase I trials of products of recombinant DNA technology.
Begent
R
R
Department of Clinical Oncology, Royal Free Hospital School of Medicine, London, U.K.
D000818:Animals; D017321:Clinical Trials, Phase I as Topic; D004274:DNA, Recombinant; D005818:Genetic Engineering; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D011994:Recombinant Proteins / Q000096:biosynthesis
D004274:DNA, Recombinant; D011994:Recombinant Proteins